-
1
-
-
1842479859
-
Diagnosis, management, and treatment of hepatitis C
-
Strader DB, Wright T, Thomas DL, Seeff LB, (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39: 1147-1171.
-
(2004)
Hepatology
, vol.39
, pp. 1147-1171
-
-
Strader, D.B.1
Wright, T.2
Thomas, D.L.3
Seeff, L.B.4
-
2
-
-
0030587906
-
Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group
-
Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, et al. (1996) Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 125: 634-639.
-
(1996)
Ann Intern Med
, vol.125
, pp. 634-639
-
-
Zein, N.N.1
Rakela, J.2
Krawitt, E.L.3
Reddy, K.R.4
Tominaga, T.5
-
3
-
-
10344259671
-
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
-
Dusheiko G, Main J, Thomas H, Reichard O, Lee C, et al. (1996) Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol 25: 591-598.
-
(1996)
J Hepatol
, vol.25
, pp. 591-598
-
-
Dusheiko, G.1
Main, J.2
Thomas, H.3
Reichard, O.4
Lee, C.5
-
4
-
-
0028202422
-
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey
-
McOmish F, Yap PL, Dow BC, Follett EA, Seed C, et al. (1994) Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32: 884-892.
-
(1994)
J Clin Microbiol
, vol.32
, pp. 884-892
-
-
McOmish, F.1
Yap, P.L.2
Dow, B.C.3
Follett, E.A.4
Seed, C.5
-
5
-
-
0028812140
-
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group
-
Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, et al. (1995) Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 122: 161-168.
-
(1995)
Ann Intern Med
, vol.122
, pp. 161-168
-
-
Nousbaum, J.B.1
Pol, S.2
Nalpas, B.3
Landais, P.4
Berthelot, P.5
-
6
-
-
0027193157
-
Differences in the hepatitis C virus genotypes in different countries
-
Takada N, Takase S, Takada A, Date T, (1993) Differences in the hepatitis C virus genotypes in different countries. J Hepatol 17: 277-283.
-
(1993)
J Hepatol
, vol.17
, pp. 277-283
-
-
Takada, N.1
Takase, S.2
Takada, A.3
Date, T.4
-
7
-
-
33645992473
-
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
-
Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, et al. (2006) Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 130: 1086-1097.
-
(2006)
Gastroenterology
, vol.130
, pp. 1086-1097
-
-
Berg, T.1
von Wagner, M.2
Nasser, S.3
Sarrazin, C.4
Heintges, T.5
-
8
-
-
1542378867
-
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
-
Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, et al. (2004) Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346-355.
-
(2004)
Ann Intern Med
, vol.140
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette Jr., H.2
Morgan, T.R.3
Balan, V.4
Diago, M.5
-
9
-
-
1442308277
-
Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?
-
Zeuzem S, (2004) Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 140: 370-381.
-
(2004)
Ann Intern Med
, vol.140
, pp. 370-381
-
-
Zeuzem, S.1
-
10
-
-
2442683905
-
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3
-
Zeuzem S, Hultcrantz R, Bourliere M, Goeser T, Marcellin P, et al. (2004) Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J Hepatol 40: 993-999.
-
(2004)
J Hepatol
, vol.40
, pp. 993-999
-
-
Zeuzem, S.1
Hultcrantz, R.2
Bourliere, M.3
Goeser, T.4
Marcellin, P.5
-
11
-
-
36348981708
-
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial
-
Jacobson IM, Brown RS Jr, Freilich B, Afdhal N, Kwo PY, et al. (2007) Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial. Hepatology 46: 971-981.
-
(2007)
Hepatology
, vol.46
, pp. 971-981
-
-
Jacobson, I.M.1
Brown Jr., R.S.2
Freilich, B.3
Afdhal, N.4
Kwo, P.Y.5
-
12
-
-
33746564989
-
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment
-
Sanchez-Tapias JM, Diago M, Escartin P, Enriquez J, Romero-Gomez M, et al. (2006) Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment. Gastroenterology 131: 451-460.
-
(2006)
Gastroenterology
, vol.131
, pp. 451-460
-
-
Sanchez-Tapias, J.M.1
Diago, M.2
Escartin, P.3
Enriquez, J.4
Romero-Gomez, M.5
-
13
-
-
40549128699
-
Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatment
-
Nakamura M, Saito H, Ikeda M, Tada S, Kumagai N, et al. (2008) Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatment. J Med Virol 80: 632-639.
-
(2008)
J Med Virol
, vol.80
, pp. 632-639
-
-
Nakamura, M.1
Saito, H.2
Ikeda, M.3
Tada, S.4
Kumagai, N.5
-
14
-
-
0034010610
-
Immunological and virological predictors of outcome during interferon-alpha therapy of chronic hepatitis C
-
Saito H, Ebinuma H, Satoh I, Miyaguchi S, Tada S, et al. (2000) Immunological and virological predictors of outcome during interferon-alpha therapy of chronic hepatitis C. J Viral Hepat 7: 64-74.
-
(2000)
J Viral Hepat
, vol.7
, pp. 64-74
-
-
Saito, H.1
Ebinuma, H.2
Satoh, I.3
Miyaguchi, S.4
Tada, S.5
-
15
-
-
0036376634
-
The detection of IRF-1 promoter polymorphisms and their possible contribution to T helper 1 response in chronic hepatitis C
-
Saito H, Tada S, Wakabayashi K, Nakamoto N, Takahashi M, et al. (2002) The detection of IRF-1 promoter polymorphisms and their possible contribution to T helper 1 response in chronic hepatitis C. J Interferon Cytokine Res 22: 693-700.
-
(2002)
J Interferon Cytokine Res
, vol.22
, pp. 693-700
-
-
Saito, H.1
Tada, S.2
Wakabayashi, K.3
Nakamoto, N.4
Takahashi, M.5
-
16
-
-
36248957151
-
Introduction to artificial neural networks
-
Grossi E, Buscema M, (2007) Introduction to artificial neural networks. Eur J Gastroenterol Hepatol 19: 1046-1054.
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, pp. 1046-1054
-
-
Grossi, E.1
Buscema, M.2
-
17
-
-
0042884371
-
Neural network based optimization of drug formulations
-
Takayama K, Fujikawa M, Obata Y, Morishita M, (2003) Neural network based optimization of drug formulations. Adv Drug Deliv Rev 55: 1217-1231.
-
(2003)
Adv Drug Deliv Rev
, vol.55
, pp. 1217-1231
-
-
Takayama, K.1
Fujikawa, M.2
Obata, Y.3
Morishita, M.4
-
18
-
-
0028788276
-
Application of artificial neural networks to clinical medicine
-
Baxt WG, (1995) Application of artificial neural networks to clinical medicine. Lancet 346: 1135-1138.
-
(1995)
Lancet
, vol.346
, pp. 1135-1138
-
-
Baxt, W.G.1
-
20
-
-
33846683604
-
International experience on the use of artificial neural networks in gastroenterology
-
Grossi E, Mancini A, Buscema M, (2007) International experience on the use of artificial neural networks in gastroenterology. Dig Liver Dis 39: 278-285.
-
(2007)
Dig Liver Dis
, vol.39
, pp. 278-285
-
-
Grossi, E.1
Mancini, A.2
Buscema, M.3
-
21
-
-
36248953324
-
The use of artificial neural network in gastroenterology: the experience of the first 10 years
-
Pace F, Savarino V, (2007) The use of artificial neural network in gastroenterology: the experience of the first 10 years. Eur J Gastroenterol Hepatol 19: 1043-1045.
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, pp. 1043-1045
-
-
Pace, F.1
Savarino, V.2
-
22
-
-
0031781450
-
The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users
-
Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, et al. (1998) The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol 10: 485-489.
-
(1998)
Eur J Gastroenterol Hepatol
, vol.10
, pp. 485-489
-
-
Haydon, G.H.1
Flegg, P.J.2
Blair, C.S.3
Brettle, R.P.4
Burns, S.M.5
-
23
-
-
3042684526
-
Artificial neural networks for the prediction of response to interferon plus ribavirin treatment in patients with chronic hepatitis C
-
Maiellaro PA, Cozzolongo R, Marino P, (2004) Artificial neural networks for the prediction of response to interferon plus ribavirin treatment in patients with chronic hepatitis C. Curr Pharm Des 10: 2101-2109.
-
(2004)
Curr Pharm Des
, vol.10
, pp. 2101-2109
-
-
Maiellaro, P.A.1
Cozzolongo, R.2
Marino, P.3
-
24
-
-
36248986257
-
Prediction of outcome in acute lower gastrointestinal hemorrhage: role of artificial neural network
-
Das A, Wong RC, (2007) Prediction of outcome in acute lower gastrointestinal hemorrhage: role of artificial neural network. Eur J Gastroenterol Hepatol 19: 1064-1069.
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, pp. 1064-1069
-
-
Das, A.1
Wong, R.C.2
-
25
-
-
0142155223
-
Prediction of outcome in acute lower-gastrointestinal haemorrhage based on an artificial neural network: internal and external validation of a predictive model
-
Das A, Ben-Menachem T, Cooper GS, Chak A, Sivak MV Jr, et al. (2003) Prediction of outcome in acute lower-gastrointestinal haemorrhage based on an artificial neural network: internal and external validation of a predictive model. Lancet 362: 1261-1266.
-
(2003)
Lancet
, vol.362
, pp. 1261-1266
-
-
Das, A.1
Ben-Menachem, T.2
Cooper, G.S.3
Chak, A.4
Sivak Jr., M.V.5
-
26
-
-
0031871764
-
Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors
-
Haydon GH, Jalan R, Ala-Korpela M, Hiltunen Y, Hanley J, et al. (1998) Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors. J Viral Hepat 5: 255-264.
-
(1998)
J Viral Hepat
, vol.5
, pp. 255-264
-
-
Haydon, G.H.1
Jalan, R.2
Ala-Korpela, M.3
Hiltunen, Y.4
Hanley, J.5
-
27
-
-
0036792679
-
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
-
Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97: 2614-2618.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2614-2618
-
-
Regev, A.1
Berho, M.2
Jeffers, L.J.3
Milikowski, C.4
Molina, E.G.5
-
28
-
-
34748866821
-
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
-
Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, et al. (2007) Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b. J Med Virol 79: 1686-1695.
-
(2007)
J Med Virol
, vol.79
, pp. 1686-1695
-
-
Akuta, N.1
Suzuki, F.2
Kawamura, Y.3
Yatsuji, H.4
Sezaki, H.5
-
29
-
-
34547428001
-
Predictors of response of US veterans to treatment for the hepatitis C virus
-
Backus LI, Boothroyd DB, Phillips BR, Mole LA, (2007) Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology 46: 37-47.
-
(2007)
Hepatology
, vol.46
, pp. 37-47
-
-
Backus, L.I.1
Boothroyd, D.B.2
Phillips, B.R.3
Mole, L.A.4
-
30
-
-
0034632938
-
Formula optimization of theophylline controlled-release tablet based on artificial neural networks
-
Takayama K, Morva A, Fujikawa M, Hattori Y, Obata Y, et al. (2000) Formula optimization of theophylline controlled-release tablet based on artificial neural networks. J Control Release 68: 175-186.
-
(2000)
J Control Release
, vol.68
, pp. 175-186
-
-
Takayama, K.1
Morva, A.2
Fujikawa, M.3
Hattori, Y.4
Obata, Y.5
-
31
-
-
0041733248
-
Clinical application of artificial neural network (ANN) modelling to predict pharmacokinetic parameters of severely ill patients
-
Yamamura S, (2003) Clinical application of artificial neural network (ANN) modelling to predict pharmacokinetic parameters of severely ill patients. Adv Drug Deliv Rev 55: 1233-1251.
-
(2003)
Adv Drug Deliv Rev
, vol.55
, pp. 1233-1251
-
-
Yamamura, S.1
-
32
-
-
0025934806
-
Use of an artificial neural network for the diagnosis of myocardial infarction
-
Baxt WG, (1991) Use of an artificial neural network for the diagnosis of myocardial infarction. Ann Intern Med 115: 843-848.
-
(1991)
Ann Intern Med
, vol.115
, pp. 843-848
-
-
Baxt, W.G.1
-
33
-
-
58149380829
-
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors
-
Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, et al. (2008) Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology 48: 1753-1760.
-
(2008)
Hepatology
, vol.48
, pp. 1753-1760
-
-
Shirakawa, H.1
Matsumoto, A.2
Joshita, S.3
Komatsu, M.4
Tanaka, N.5
-
34
-
-
31644439149
-
Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication
-
Liu S, Ansari IH, Das SC, Pattnaik AK, (2006) Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication. J Gen Virol 87: 323-327.
-
(2006)
J Gen Virol
, vol.87
, pp. 323-327
-
-
Liu, S.1
Ansari, I.H.2
Das, S.C.3
Pattnaik, A.K.4
-
35
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
Ge D, Fellay J, Thompson A, Simon J, Shianna K, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nat Genet 461: 399-401.
-
(2009)
Nat Genet
, vol.461
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.3
Simon, J.4
Shianna, K.5
-
36
-
-
70349533037
-
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
-
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
-
(2009)
Nat Genet
, vol.41
, pp. 1105-1109
-
-
Tanaka, Y.1
Nishida, N.2
Sugiyama, M.3
Kurosaki, M.4
Matsuura, K.5
-
37
-
-
70349548852
-
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
-
Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
-
(2009)
Nat Genet
, vol.41
, pp. 1100-1104
-
-
Suppiah, V.1
Moldovan, M.2
Ahlenstiel, G.3
Berg, T.4
Weltman, M.5
-
38
-
-
79953298817
-
IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection
-
Lin CY, Chen JY, Lin TN, Jeng WJ, Huang CH, et al. (2011) IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection. PLoS ONE 6: e21854.
-
(2011)
PLoS ONE
, vol.6
-
-
Lin, C.Y.1
Chen, J.Y.2
Lin, T.N.3
Jeng, W.J.4
Huang, C.H.5
-
39
-
-
79960081869
-
An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C
-
O'Brien TR, Everhart JE, Morgan TR, Lok AS, Chung RT, et al. (2011) An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. PLoS ONE 6: e20904.
-
(2011)
PLoS ONE
, vol.6
-
-
O'Brien, T.R.1
Everhart, J.E.2
Morgan, T.R.3
Lok, A.S.4
Chung, R.T.5
-
40
-
-
79960022080
-
Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C
-
Cyr DD, Lucas JE, Thompson JW, Patel K, Clark PJ, et al. (2011) Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. PLoS ONE 6: e21854.
-
(2011)
PLoS ONE
, vol.6
-
-
Cyr, D.D.1
Lucas, J.E.2
Thompson, J.W.3
Patel, K.4
Clark, P.J.5
-
41
-
-
77952693487
-
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin
-
McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, et al. (2010) Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 138: 2307-2314.
-
(2010)
Gastroenterology
, vol.138
, pp. 2307-2314
-
-
McCarthy, J.J.1
Li, J.H.2
Thompson, A.3
Suchindran, S.4
Lao, X.Q.5
-
42
-
-
77956882389
-
Creation of a tablet database containing several active ingredients and prediction of their pharmaceutical characteristics based on ensemble artificial neural networks
-
Takagaki K, Arai H, Takayama K, (2010) Creation of a tablet database containing several active ingredients and prediction of their pharmaceutical characteristics based on ensemble artificial neural networks. J Pharm Sci 99: 4201-4214.
-
(2010)
J Pharm Sci
, vol.99
, pp. 4201-4214
-
-
Takagaki, K.1
Arai, H.2
Takayama, K.3
|